4//SEC Filing
Echo Therapeutics, Inc. 4
Accession 0001415889-16-004932
CIK 0001031927operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 2:31 PM ET
Size
5.7 KB
Accession
0001415889-16-004932
Insider Transaction Report
Form 4
Edelman Elazer R
Director
Transactions
- Award
Options (Right to Buy)
2016-03-01+150,000→ 37,500 totalExercise: $1.12Exp: 2026-03-01→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]25% of the options vest immediately and 25% vest on each of July 1, 2016, October 1, 2016 and January 1, 2017.
- [F2]Granted pursuant to the Echo Therapeutics, Inc. 2008 Equity Compensation Plan.
Documents
Issuer
Echo Therapeutics, Inc.
CIK 0001031927
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001031927
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 2:31 PM ET
- Size
- 5.7 KB